Procare Health

What Procare Health does

Procare Health is a privately held Spanish pharmaceutical laboratory founded in 2012, specializing in women's health across the full reproductive lifecycle. The company develops and commercializes bio-optimized natural-ingredient formulations organized into four therapeutic areas: genital infections (notably Papilocare for HPV-related cervical lesions, with clinical evidence of 88% lesion normalization and 63% high-risk HPV clearance in 600+ patients per the Paloma study), fertility and pregnancy support (Ovosicare, Gestacare, Ironcare), menopause management (Libicare, Menocare, Idracare), and osteoarthritis (Pronolis viscosupplementation, Dolocare, Dcare). The portfolio spans medical devices, pharmaceuticals, and dietary supplements, with ongoing R&D into therapeutic vaccines for gynecological cancers and Cervix-on-a-Chip research platforms. R&D investment is stated at 25% of budget, supported by over 20 clinical and observational studies and 100+ scientific presentations.

The company operates through a hybrid commercial model combining wholly-owned subsidiaries in France, Portugal, the United Kingdom, and Italy for direct sales, with licensing partnerships to regional pharmaceutical companies across Latin America, the Middle East, Africa, Asia-Pacific, and Australia for international expansion. Products are distributed primarily through pharmacy retail and medical-channel prescription, supplemented by the My Farmacia online platform. Geographic reach is reported between 45 and 75+ countries depending on source and metric, with active expansion into the Chinese market and a pipeline of pending approvals in 65+ additional countries. In January 2025, the company divested its women's health nutraceutical assets to Exeltis (part of Insud Pharma) as a portfolio realignment. Leadership includes CEO Yann Gaslain and co-founder Carine Emsellem (VP Marketing & Scientific Affairs), with headquarters in Benifaio (Valencia) and Castelldefels (Barcelona), Spain, and 51-100 employees.

Name

Procare Health

Legal name

PROCARE HEALTH IBERIA SL

Website

https://procarehealth.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

51–100 employees

Short description

Procare Health is a privately held Spanish pharmaceutical laboratory founded in 2012 that develops and commercializes bio-optimized natural-ingredient women's health products across HPV/cervical care, fertility, pregnancy, menopause, and osteoarthritis, distributed in over 45 countries via subsidiaries and pharmaceutical licensing partners.

Ownership category

akta.pro rank

Product category

Women's Health Pharmaceuticals

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Women’s Health & Reproductive Specialty Pharmaceuticals (HLAIACAN)

akta.pro secondary industries

Specialty Care Pharmaceuticals (HLAIAAAB), Women’s Health Supplements (Prenatal, Menopause, Hormonal) (CRADAGAK)

Keywords

• Women's health pharmaceuticals
• Gynecological therapeutics
• Fertility supplements
• HPV treatment products
• Menopause management

Headquarters

HQ city

Castelldefels

HQ country

Spain

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Pharmaceutical and nutraceutical product sales: Sale of pharmaceutical products, medical devices, and dietary supplements for women's health including Papilocare, Ovosicare, Palomacare, Libicare, and menopause products through pharmacy and medical channels
2. Product licensing: Out-licensing of proprietary formulations to pharmaceutical partners in international markets (America, Middle East, Africa, Asia, Australia)
3. International subsidiary sales: Direct commercialization through owned subsidiaries in France and Portugal

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Procare Health is a Spanish pharmaceutical laboratory that develops, manufactures, and commercializes women's health products across the life cycle, covering HPV/cervical lesions, fertility, pregnancy, menopause, sexual health, and osteoarthritis. The portfolio spans pharmaceuticals, medical devices, dermocosmetics, and dietary supplements built on bio-optimized natural ingredients with documented clinical evidence, sold through pharmacy networks, the company's own online platform, and out-licensing partnerships with international pharmaceutical companies.

Product overview

Procare Health is a Spanish pharmaceutical laboratory specializing in women's health with a diversified portfolio of therapeutic products. The company operates across four main therapeutic areas: Genital Infections (Papilocare® for HPV/cervical lesions, Palomacare® product line for vaginal health including Crispatus and Ovulos variants, Herpecare® for herpes, Ciscare® for urinary wellness), Fertility and Pregnancy (Ovosicare® Fertility and Ovosicare® ProFIV for reproductive support, Gestacare® for pregnancy/lactation, Ironcare® Forte for iron supplementation), Menopause (Libicare® product line including Meno and ONE variants, Menocare® for hot flashes/sleep, Idracare® for vaginal hydration), and Osteoarthritis (Pronolis® HD viscosupplementation in multiple concentrations, Dolocare® Forte/Flex for joint flexibility, Dcare® Forte/K2 for bone health). Products are formulated with bio-optimized natural ingredients and are commercialized in over 45 countries through subsidiaries in France and Portugal, and licensing partnerships across America, Middle East, Africa, Asia, and Australia.

Differentiator

Problem solved

Functional benefit

Brands

• Papilocare: Treatment and prevention of cervical lesions caused by HPV
• Palomacare
• Ovosicare
• Gestacare
• Libicare
• Idracare
• Menocare
• Herpecare
• Ciscare
• Ironcare
• DCare
• Dolocare
• Pronolis
• Papilocare Immunocaps

Products and services

• Papilocare Gel formulation indicated for HPV and cervical lesions, with the Paloma clinical study demonstrating 88% normalization of cervical lesions and 63% HPV clearance; targeted at gynecologists and women undergoing HPV or cervical lesion management.
• Papilocare Immunocaps
• Palomacare
• Palomacare Crispatus
• Palomacare Óvulos
• Palomacare Vulvisens
• Herpecare
• Ciscare
• Ovosicare Fertility
• Ovosicare ProFIV
• Gestacare
• Ironcare Forte
• Libicare Meno
• Libicare ONE
• Libicare
• Idracare
• Menocare
• Dolocare Forte
• Dolocare Flex
• DCare Forte
• DCare K2
• Pronolis HD

Quantifiable outcome

• 88% cervical lesion normalization rate with Papilocare vaginal gel (Paloma clinical study, 600+ patients)
• +1 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

16 partnerships are on record, tiered core and minor.

• Exeltis (part of Insud Pharma)coreChannel Partner/ Reseller/ Distributor · 1 January 2025Exeltis acquired women's health nutraceutical assets from Procare Health in January 2025 as part of a strategic portfolio realignment, transferring commercialization rights for certain nutraceutical products.
• SantefarmminorChannel Partner/ Reseller/ DistributorEuropean distribution partner for Procare Health products
• CHENANminorChannel Partner/ Reseller/ DistributorLatin American distribution partner for Procare Health products
• MegalabsminorChannel Partner/ Reseller/ DistributorLatin American pharmaceutical partner for product distribution
• LupinminorChannel Partner/ Reseller/ DistributorGlobal pharmaceutical company as distribution partner
• LabatecminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner for Procare Health products
• ElpenminorChannel Partner/ Reseller/ DistributorGreek pharmaceutical distribution partner
• LunatusminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner for Middle East markets
• Oktal PharmaminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner
• ACX ConsultingminorChannel Partner/ Reseller/ DistributorConsulting partner for distribution services
• ZAS CorporationminorChannel Partner/ Reseller/ DistributorDistribution partner for Procare Health products
• Premier SurgicalminorChannel Partner/ Reseller/ DistributorDistribution partner
• VecopharmminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner
• Hynebio PharmaminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner
• MedispharmminorChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner
• International medical institutions and universitiescoreStrategic or Co-development PartnerCollaborative research partnerships with international medical institutions including Harvard University, conducting clinical studies and research projects on women's health solutions

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• Endoceutics: Specialty pharmaceutical company focused on women's health, menopause (e.g., intrinsic therapeutics), androgens, and gynecological conditions — comparable niche women's-health specialty model with a research-driven positioning.

Direct peers

• Effik: European specialty pharmaceutical company focused on women's health (contraception, menopause, gynecology) — similar specialty-pharma model and Pan-European presence, comparable in size and therapeutic mix to Procare.
• Italfarmaco: Italian specialty pharmaceutical company with a focus on women's health, gynecology, and rare diseases — overlapping with Procare on menopause, vaginal health, and OB/GYN prescription products in Southern Europe.
• Exeltis (Insud Pharma): Global women's health division of Insud Pharma that acquired Procare's nutraceutical assets in January 2025; directly competes with Procare's remaining portfolio and is now both a partial acquirer and a competitor in women's health.
• Theramex: UK-headquartered specialty pharmaceutical company exclusively focused on women's health — covering contraception, fertility, menopause, and osteoporosis — with a similar specialty-pharma model and pan-European commercial footprint.

Regional players

• Seid Lab: Spanish specialty pharmaceutical company with a women's health portfolio including contraception, menopause, and vaginal health products — a direct regional competitor to Procare in the Spanish pharmacy channel.

Broad incumbents

• Organon & Co. Global women's health specialty pharmaceutical company (Merck spinoff) with franchises in contraception, fertility, HPV, and menopause — overlapping directly with Procare's Papilocare, Ovosicare, and Libicare categories, but at much larger scale.
• Gedeon Richter: Hungarian-headquartered specialty pharmaceutical company with a sizeable women's health portfolio (contraception, menopause, fertility) and growing Western European presence — directly comparable specialty-pharma model.
• Shionogi (Women's Health / HPV): Japanese multinational with established women's health and HPV-related assets (e.g., cervical cancer vaccines) — a broader incumbent whose HPV/cervical health franchises directly overlap with Procare's Papilocare focus.
• Bayer (Women's Health / Pharma): Major multinational pharmaceutical company with established women's health, contraception, and menopause franchises (e.g., Mirena, Yaz) — a large incumbent operating in Procare's core therapeutic categories with substantially greater resources.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInes.linkedin.com/company/procare-health
• Instagraminstagram.com/procarehealthiberia

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Procare Health